Equities

Nattopharma ASA

Nattopharma ASA

Actions
Consumer GoodsFood Producers
  • Price (NOK)8.00
  • Today's Change-0.75 / -8.57%
  • Shares traded4.80k
  • 1 Year change-13.98%
  • Beta0.7899
Data delayed at least 15 minutes, as of Aug 23 2019 15:15 BST.
More ▼

Events & Activity

  • NATTO:OSL reported earnings of -0.07 for the period of the year 2019Q2.
  • NATTO:OSL price moved over -15.05% to 8.75
  • NATTO:OSL price falls below 200-day moving average to 8.75 at 10:30 BST
  • NATTO:OSL trading volume exceeds daily average by +31.45%
  • NATTO:OSL price falls below 50-day moving average to 8.75 at 10:30 BST
  • NATTO:OSL price falls below 15-day moving average to 8.75 at 10:30 BST

Key statistics

On Friday, Nattopharma ASA (NATTO:OSL) closed at 8.00, 1.91% above its 52-week low of 7.85, set on Sep 12, 2018.
52-week range
Today
7.85Sep 12 201813.50Mar 11 2019
Open8.70
High8.70
Low8.00
Bid8.00
Offer8.70
Previous close8.75
Average volume7.71k
Shares outstanding18.18m
Free float7.78m
P/E (TTM)99.39
Market cap145.44m NOK
EPS (TTM)0.0805
NOK
Data delayed at least 15 minutes, as of Aug 23 2019 15:15 BST.
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.